all countries, CRS&HIPEC, research, Treatment
Pseudomyxoma peritonei (PMP) is a rare malignant disease characterized by the progressive and multifocal accumulation of abundant mucinous tumour tissue in the peritoneal cavity. It is generally associated with a perforated epithelial neoplasm of the appendix. The...
all countries, Basingstoke, research
Pseudomyxoma Survivor is supporting exciting new research into the biology of pseudomyxoma peritonei. The study is a collaboration between the Peritoneal Malignancy Institute, Basingstoke, and the Cancer Sciences Unit, University of Southampton. It analyses gene...
all countries, patient advocacy, research, Volunteering
In December, Susan and Angela have been asked to present at the EuroPMP International Workshop on pseudomyxoma peritonei. It is a privilege to be asked to present to this network of experts from many fields, including surgeons, pathologists, oncologists, radiologists,...
all countries, diagnosis, research, Treatment
The BMJ defines evidence-based medicine¹ as: “the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients” It’s a constantly evolving definition and at Pseudomyxoma Survivor, we...
all countries, in the news, raising awareness, research
The PERITONEAL SURFACE ONCOLOGY GROUP INTERNATIONAL conference (PSOGI2018), now in its 11th year, is almost upon us. I can’t quite believe it’s been two years since we attended the one in Washington DC! PSOGI is a non-profit organisation which aims to...
Recent Comments